Postpartum Uterine Bleeding Clinical Trial
Official title:
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Verified date | March 2013 |
Source | Glenveigh Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
This is an open, post-marketing surveillance study obtaining data retrospectively on 300 women, of any age, treated with the BD-OTS for postpartum uterine bleeding.
Status | Terminated |
Enrollment | 300 |
Est. completion date | October 2012 |
Est. primary completion date | October 2012 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Treatment with the BD-OTS device Exclusion Criteria: |
Observational Model: Case-Only, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
United States | North Austin Medical Center - St. David's Women's Center of Texas | Austin | Texas |
United States | St. David's Medical Center | Austin | Texas |
United States | Medical University of South Carolina | Charleston | South Carolina |
United States | Erlanger | Chattanooga | Tennessee |
United States | University of Cincinnati | Cincinnati | Ohio |
United States | Presbyterian/St. Luke's Medical Center | Denver | Colorado |
United States | UHS - Wilson Medical Center | Johnson City | New York |
United States | Monmouth Medical Center | Long Branch | New Jersey |
United States | Orlando Health | Orlando | Florida |
United States | Banner Good Samaritan Medical Center | Phoenix | Arizona |
United States | Toledo Hospital | Toledo | Ohio |
Lead Sponsor | Collaborator |
---|---|
Glenveigh Medical |
United States,